中国引进抗艾滋药物韦瑞德
2011-10-04 01:59:00 来源: 济南日报
据新华社北京10月3日电 记者日前从葛兰素史克(中国)公司获悉，通过吉利德科学公司的一项专利使用权转让协议，葛兰素史克公司获得独家权利在我国自费市场上市韦瑞德(又称替诺福韦)，用于治疗艾滋病。这将为艾滋病患者带来新的治疗选择。
作为全球第一个用于艾滋病治疗的核苷酸类似物抗病毒药物，替诺福韦是一种新型核苷酸类逆转录酶抑制剂，通过阻断涉及艾滋病病毒复制的逆转录酶，从而抑制病毒复制。
(本文来源：舜网-济南日报作者： 周婷玉 )
艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复
 |
| 图示∶2011年5月正式出版的《中国特色医疗金鉴》登载的刘君主任及其机构事迹 |
| |
|
|
China to introduce anti-HIV drugs Weirui De
2011-10-04 01:59:00 Source: Jinan Daily
According to the Xinhua News Agency, Beijing, October 3 - Reporters from GlaxoSmithKline (China) Company was informed by Gilead Sciences Inc., a patent licensing agreement, GSK received exclusive rights to market our own expense listed Weirui De (also known as tenofovir), for the treatment of AIDS. This will bring new AIDS treatment options.
As the world's first treatment for AIDS antiviral nucleotide analogues, tenofovir is a new nucleotide reverse transcriptase inhibitors, by blocking HIV replication involving reverse transcriptase, thereby inhibiting viral replication.
(This article Source: Shun Net - Jinan Daily Author: Zhou Tingyu)
|
